We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Issues Draft Guidance on Biosimilar Product Development

News   Feb 13, 2012

 
FDA Issues Draft Guidance on Biosimilar Product Development
 
 
Advertisement
 

RELATED ARTICLES

Trial Investigates Remdesivir–Baricitinib Combo as COVID-19 Treatment

News

Following on from remdesivir’s promising results from previous studies, a new trial is now investigating remdesivir in combination with baricitinib or placebo as a treatment for COVID-19, in a double-blind, randomized trial.

READ MORE

Anti-malarial Drug Shows Potential as Brain Cancer Treatment in Preclinical Models

News

In vitro studies have uncovered new insights that could help increase the effectiveness of the most common current treatments with the addition of lumefantrine, an FDA-approved drug used to treat malaria.

READ MORE

Antibody Designed To Identify Toxic Particles That Destroy Healthy Brain in Alzheimer’s Disease

News

Researchers have discovered a way to design an antibody that can identify the toxic particles that destroy healthy brain cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE